Advertisement
Table 1 Baseline summary data: demographic and outcome measures
| Measure | Intervention Mean (SD) | Control Mean (SD) | All Mean (SD) | Significance (p) |
|---|---|---|---|---|
| Age (years) | 75.25 (5.78) | 74.30(5.72) | 74.28 (5.87) | 0.63 |
| Gender | Frequency | Frequency | Frequency | |
| Male | 2 | 9 | 11 | 0.06 |
| Female | 12 | 9 | 21 | |
| GDS† | 12.64 (3.61) | 12.22 (3.51) | 12.41 (3.50) | 0.88 |
| CES-D | 19.71 (6.40) | 16.61 (6.22) | 17.96 (6.39) | 0.31 |
| PGMS†* | 8.77 (3.32) | 9.23 (3.01) | 9.03 (3.10) | 0.69 |
| HAP MAS | 69.79 (7.64) | 67.17 (9.99) | 68.31(8.99) | 0.12 |
| HAP AAS | 55.86(11.71) n = 14 | 51.61 (16.12) n = 18 | 53.47 (14.30) n = 32 | 0.07 |
| WHO QOL DOM 1** | 12.86 (3.27) | 13.34 (2.48) | 13.13 (2.81) | 0.89 |
| WHO QOL DOM 2** | 13.19 (1.55) | 12.86 (2.14) | 13.00(1.88 | 0.19 |
| WHO QOL DOM 3** | 13.14 (3.08) | 13.94 (3.94) | 13.59 (3.55) | 0.66 |
| WHO QOL DOM 4** | 14.89 (1.91) | 15.62 (2.34) | 15.30 (2.16) | 0.46 |
| Self Efficacy | 16.21 (4.90) | 15.88 (4.01) | 16.03 (4.35) | 0.35 |
| PASE | 145.03 (68.11) | 111.25 (67.21) | 126.03 (68.65) | 0.06 |
